Efficacy and Safety of Apixaban, Dabigatran, Rivaroxaban, and Warfarin in Asians With Nonvalvular Atrial Fibrillation
ESC 2015 Meeting Report
Anticoagulation in the Post-Warfarin Era: Where Are We Today?
No INRs! RNs Role Caring for Patients on Oral Anticoagulant Therapy - ppt download
GI bleeding on anticoagulants
Advantages and Disadvantages of Novel Oral Anticoagulants | DAIC
Figure 43, Forest plot for gastrointestinal bleeding—apixaban, rivaroxaban, or edoxaban (treatment) versus dabigatran (control) (observational) - Stroke Prevention in Patients With Atrial Fibrillation: A Systematic Review Update - NCBI Bookshelf
Non-major bleeding with apixaban versus warfarin in patients with atrial fibrillation | Heart
What gastroenterologists should know about direct oral anticoagulants - Digestive and Liver Disease
Frontiers | Effectiveness and Safety of Under or Over-dosing of Direct Oral Anticoagulants in Atrial Fibrillation: A Systematic Review and Meta-analysis of 148909 Patients From 10 Real-World Studies | Pharmacology
Figure 32, Forest plot for gastrointestinal bleeding—apixaban, rivaroxaban, or edoxaban (treatment) versus warfarin (control) (observational) - Stroke Prevention in Patients With Atrial Fibrillation: A Systematic Review Update - NCBI Bookshelf
Comparison of Once-Daily Administration of Edoxaban and Rivaroxaban in Asian Patients with Atrial Fibrillation | Scientific Reports
Libraries Back Pharmacist Pharmacist CE LibraryMTM Certificate ProgramVeterinary Pharmacy Certificate ProgramLaw Library for PharmacistsMedication Safety for Pharmacists Pharmacy Technician Pharmacy Technician LibraryMTM Certificate Program ...
Bleeding outcomes. A) Major bleeding: All four new oral anticoagulants... | Download Scientific Diagram
What gastroenterologists should know about direct oral anticoagulants - Digestive and Liver Disease
Through Thick and Thin: approaches to anticoagulant Reversal - ppt video online download
Advantages and Disadvantages of Novel Oral Anticoagulants | DAIC
Dabigatran, rivaroxaban, and apixaban are superior to warfarin in Asian patients with non-valvular atrial fibrillation: An updated meta-analysis
Target-Specific Oral Anticoagulants
Non-major bleeding with apixaban versus warfarin in patients with atrial fibrillation | Heart
Better clinical outcomes with DOACs vs. warfarin in patients with NVAF and low body weight - PACE-CME
Overall Rates of GI Bleeding by Treatment Arm | Download Table
Comparative risk of gastrointestinal bleeding with dabigatran, rivaroxaban, and warfarin: population based cohort study | The BMJ
New predictive model for acute gastrointestinal bleeding in patients taking oral anticoagulants: A cohort study - Shimomura - 2018 - Journal of Gastroenterology and Hepatology - Wiley Online Library
Dabigatran, rivaroxaban, and apixaban are superior to warfarin in Asian patients with non-valvular atrial fibrillation: An updated meta-analysis
